Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023
WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research published in the May 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Cassandra M. Pickens, Ph.D., from the CDC in Atlanta, and colleagues analyzed quarterly trends in rates of suspected nonfatal overdose of unintentional or undetermined intent involving fentanyl or fentanyl analogs overall and by age group, sex, and race and ethnicity.
The researchers found an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits of 8.7 percent per quarter during quarter (Q) 4 of 2020 to Q3 of 2023, from 1.4 to 3.5 per 10,000 emergency department visits, followed by an 11.0 percent decrease per quarter from Q3 of 2023 to Q1 of 2024, to 2.9 per 10,000 emergency department visits. Through mid-2023, trends increased among a majority of demographic groups; non-Hispanic American Indian or Alaska Native persons had the highest rates and the largest increases (e.g., 11.9 per 10,000 emergency department visits in Q3 of 2023 and an average quarterly increase of 9.0 percent).
"Ongoing monitoring of trends in fentanyl-involved nonfatal overdoses by state and local jurisdictions can identify areas in need of evidence-based prevention, treatment, and recovery support services," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Receipt of Meds for Opioid Use Disorder in Jail Increases Use After Release
TUESDAY, Sept. 23, 2025 -- Receipt of medications for opioid use disorder (MOUD) in jail is associated with an increased likelihood of receiving MOUD after community release...
High Exposure to Prenatal Prescribed Opioid Analgesics Likely Not Associated With ASD Risk
THURSDAY, Sept. 18, 2025 -- Associations are observed between high exposure to prescribed opioid analgesics (POAs) and the risk for autism spectrum disorder (ASD) or...
Over-the-Counter Naloxone Shows Limited Uptake
WEDNESDAY, Sept. 17, 2025 -- Sales of over-the-counter (OTC) naloxone increased in the United States after it was made available to the public then quickly declined...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.